OAN Employees Katherine Mosack5:00 PM – Friday, December 19, 2025
President Donald Trump introduced on Friday that 9 main pharmaceutical firms have agreed to offers aimed toward decreasing prescription drug costs for American sufferers.
Throughout a White Home occasion, leaders from these pharmaceutical firms joined the forty seventh President to unveil the agreements. The collaborating producers are Amgen, Bristol Myers Squibb, Boehringer Ingelheim, Genentech, Gilead Sciences, GSK, Merck, Novartis, and Sanofi.
Trump has lengthy highlighted the unfair burden on People, who pay far increased costs for drugs than sufferers in some other nation.
This summer time, he despatched letters to 17 pharmaceutical firms demanding that U.S. costs align with these overseas. Because the White Home said on the time, “The US has lower than 5 % of the world’s inhabitants, but roughly 75% of world pharmaceutical income come from American taxpayers.”
Below the brand new offers, costs for a number of key pharmaceuticals can be matched to the bottom charges paid globally — a coverage Trump refers to as “most favored nation” pricing.
One draw back for different nations is that their drug costs may rise barely to compensate for the lowered prices in america. Trump said that this was preferable, nevertheless, to the choice of imposing 10% tariffs.
The President took benefit of the chance to additional promote his tariffs, arguing that with out them, overseas nations wouldn’t be so simply satisfied.
“They stated, ‘Is {that a} menace?’ I stated, ‘sure, it’s a menace,’” he added. “What’s occurring, as a result of the world is greater than america … that very same tablet would go from $10 to $20 for them. … Ours would go from $130 to $20 … That’s the way in which it’s.”
Up to now, 14 of the 17 firms his administration contacted have agreed to the pricing deal, with the remaining three anticipated to formalize their agreements quickly. He joked that these three firms are in “deep hassle,” although Trump stated he believes they’ll be part of at one other time.
“As of as we speak, 14 out of the 17 largest pharmaceutical firms — however they’ve all agreed — have now agreed to drastically decrease drug costs for his or her American sufferers,” Trump continued.
The U.S. Commander-in-chief additionally supplied concrete examples of the upcoming reductions, akin to Sanofi’s blood thinner Plavix dropping from $750 to underneath $16, and Gilead’s hepatitis C remedy being reduce from almost $25,000 to lower than $2,500 — a 90% lower.
Whereas praising the pharmaceutical firms for his or her patriotic contribution to U.S. nationwide safety via these agreements, Trump additionally introduced that they’d dedicated to investing over $150 billion to develop home drug manufacturing.
The President then invited Dr. Mehmet Oz, Administrator of the Facilities for Medicare & Medicaid Providers, to supply his feedback.
Support Greater and Subscribe to view content
This is premium stuff. Subscribe to read the entire article.
